188 related articles for article (PubMed ID: 32867681)
1. Comparison of efficacy and safety of drug-eluting versus uncoated balloon angioplasty for femoropopliteal arterial occlusive disease: a meta-analysis.
Feng H; Chen X; Guo X; Zhang Z; Zhang Z; Liu B; Lian L
BMC Cardiovasc Disord; 2020 Aug; 20(1):395. PubMed ID: 32867681
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease.
Jongsma H; Bekken JA; de Vries JP; Verhagen HJ; Fioole B
J Vasc Surg; 2016 Nov; 64(5):1503-1514. PubMed ID: 27478005
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.
Katsanos K; Spiliopoulos S; Paraskevopoulos I; Diamantopoulos A; Karnabatidis D
J Endovasc Ther; 2016 Apr; 23(2):356-70. PubMed ID: 26823485
[TBL] [Abstract][Full Text] [Related]
7. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions.
Zeller T; Brechtel K; Meyer DR; Noory E; Beschorner U; Albrecht T
J Endovasc Ther; 2020 Oct; 27(5):683-690. PubMed ID: 32666871
[No Abstract] [Full Text] [Related]
8. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.
Teichgräber U; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Thieme M; Blessing E; Treitl M; Lichtenberg M; von Flotow P; Vogel B; Werk M; Riambau V; Wienke A; Lehmann T; Sixt S
Trials; 2016 Oct; 17(1):528. PubMed ID: 27793175
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis-Derived Benchmarks of Patency and Target Lesion Revascularization of Percutaneous Balloon Angioplasty from Prospective Clinical Trials of Symptomatic Femoropopliteal In-Stent Restenosis.
Shammas NW; Jones-Miller S; Lemke J
J Vasc Interv Radiol; 2016 Aug; 27(8):1195-203. PubMed ID: 27350033
[TBL] [Abstract][Full Text] [Related]
12. Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease.
Kuo TT; Chen PL; Huang CY; Lee CY; Shih CC; Chen IM
J Vasc Surg; 2019 Jan; 69(1):141-147. PubMed ID: 30104098
[TBL] [Abstract][Full Text] [Related]
13. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
Ouriel K; Adelman MA; Rosenfield K; Scheinert D; Brodmann M; Peña C; Geraghty P; Lee A; White R; Clair DG
JACC Cardiovasc Interv; 2019 Dec; 12(24):2515-2524. PubMed ID: 31575518
[TBL] [Abstract][Full Text] [Related]
14. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
15. Atherectomy plus drug-coated balloon versus drug-coated balloon only for treatment of femoropopliteal artery lesions: A systematic review and meta-analysis.
Lin F; Wang H; Ding W; Chen G; Zhang Z
Vascular; 2021 Dec; 29(6):883-896. PubMed ID: 33478353
[TBL] [Abstract][Full Text] [Related]
16. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Giacoppo D; Cassese S; Harada Y; Colleran R; Michel J; Fusaro M; Kastrati A; Byrne RA
JACC Cardiovasc Interv; 2016 Aug; 9(16):1731-42. PubMed ID: 27539695
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery Revascularization.
Zhang J; Xu X; Kong J; Xu R; Fan X; Chen J; Zheng X; Ma B; Sun M; Ye Z; Liu P
Vasc Endovascular Surg; 2017 Feb; 51(2):72-83. PubMed ID: 28103754
[TBL] [Abstract][Full Text] [Related]
18. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
[No Abstract] [Full Text] [Related]
20. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
